​

Neumora Therapeutics Ownership | Who Owns Neumora Therapeutics?

OverviewForecastFinancialsChartTranscripts

Neumora Therapeutics Ownership Summary

Neumora Therapeutics is owned by 40.40% institutional investors, 27.58% insiders, and 32.01% retail investors. Swiss national bank is the largest institutional shareholder, holding 0% of NMRA shares.

NMRA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNeumora Therapeutics40.40%27.58%32.01%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Swiss national bank---
Ecor1 capital---
Profund advisors---
Janus henderson group---
Metlife investment management---
Nelson, van denburg & campbell wealth management group---
Lindbrook capital---
Franklin resources---
Advisor group---
Pdt partners---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Swiss national bank---
Ecor1 capital---
Profund advisors---
Janus henderson group---
Metlife investment management---
Nelson, van denburg & campbell wealth management group---
Lindbrook capital---
Franklin resources---
Advisor group---
Pdt partners---

Top Buyers

HolderShares% AssetsChange
Advisor group---6.00
Gamma investing---16.00
Allworth financial lp---32.00
Ronald blue trust---38.00
Lindbrook capital---48.00

Top Sellers

HolderShares% AssetsChange
Capital investors---3.70M
Ecor1 capital---2.07M
Rock springs capital management lp---955.11K
Orbimed advisors---805.00K
Sio capital management---636.30K

Sold Out

HolderChange
Advisor group-6.00
Gamma investing-16.00
Allworth financial lp-32.00
Ronald blue trust-38.00
Lindbrook capital-48.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025116-27.95%65,233,669-16.60%401.68%62-31.11%32-
Dec 31, 202416443.86%80,367,33617.21%502.73%9253.33%3357.14%
Sep 30, 202411418.75%68,568,1827.43%422.67%60-10.45%2161.54%
Jun 30, 2024969.09%63,827,34521.38%403.62%6728.85%13-23.53%
Mar 31, 20248837.50%52,586,59620.20%334.39%5220.93%17112.50%

Recent Insider Transactions

DateNameRoleActivityValue
Feb 18, 2025BERNS PAUL L See RemarksSell$23.47K
Feb 18, 2025Milligan Michael Lee See RemarksSell$3.35K
Feb 18, 2025Aurora Daljit Singh Chief Strategy OfficerSell$14.35K
Feb 18, 2025Lenz Robert A. Head of R&DSell$9.38K
Feb 18, 2025Pinto Joshua PresidentSell$13.48K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1-5
2024 Q4-4
2024 Q3-3
2023 Q420-

NMRA Ownership FAQ

Who Owns Neumora Therapeutics?

Neumora Therapeutics shareholders are primarily institutional investors at 40.40%, followed by 27.58% insiders and 32.02% retail investors. The average institutional ownership in Neumora Therapeutics's industry, Biotech Stocks , is 63.96%, which Neumora Therapeutics falls below.

Who owns the most shares of Neumora Therapeutics?

Neumora Therapeutics’s largest shareholders are Swiss national bank (0 shares, 0%), Ecor1 capital (0 shares, 0%), and Profund advisors (0 shares, 0%). Together, they hold 0% of Neumora Therapeutics’s total shares outstanding.

Does Blackrock own Neumora Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Neumora Therapeutics.

Who is Neumora Therapeutics’s biggest shareholder by percentage of total assets invested?

Swiss national bank is Neumora Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Neumora Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools